Immune-mediated alopecias and their mechanobiological aspects

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

The conclusion is that fat tissue in the skin is a new finding in Frontal fibrosing alopecia and may contribute to hair follicle and muscle degeneration.

Personality traits and anxiety affect hair loss patients' quality of life.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Black and Hispanic women are more likely to have alopecia areata than white women.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Hair loss in black women needs more research, early intervention, and community education.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The study showed that hair follicle stem cells can maintain and organize themselves in a lab setting, keeping their ability to renew and form hair and skin.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

A new mouse model helps understand and find treatments for alopecia areata.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Hair follicles prevent NK cell attacks to avoid hair loss.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The document concludes that the hair cycle is a complex process involving growth, regression, and rest phases, regulated by various molecular signals.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Hair loss causes stress and affects mental health; treatment and support needed.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

The study found that hair follicles are above muscle connections in the scalp, which may help protect stem cell areas.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Serum from alopecia patients does not stop hair growth in grafted skin on mice.